The Crone Law Group Represents Dachang Hui Autonomous County Baosheng Steel Products Co., Ltd., in Reverse Acquisition.
The Crone Law Group, a corporate and securities law firm providing strategic legal services for emerging companies, entrepreneurs and publicly traded entities, announced today that it represented, Dachang Hui Autonomous County Baosheng Steel Products Co., Ltd., ("Buddha Steel") a Hebei, China based steel producer, in its reverse acquisition of the Bulletin Board company A.G. Volney Center, Inc. (OTC: AGVO) effective April 28, 2010. This is the third reverse acquisition completed by a CLG client in the past 8 weeks.


The Crone Law Group Represents Xingtai Longhai Wire Co., Ltd., in Reverse Acquisition.
The Crone Law Group announced today that it represented, Xingtai Longhai Wire Co., Ltd., ("Longhai Steel") a Hebei, China based steel wire producer, in its reverse acquisition of the Bulletin Board company Action Industries, Inc. (OTC: ACTN) effective March 26, 2010. This is the second reverse acquisition completed by a CLG client in the past 4 weeks.


Weikang Bio-Technology Group Co., Inc. Effectiveness Order States: S1 Goes Effective without SEC Review.
Weikang Bio-Technology Group Co., Inc.'s (OTCBB: WKBT) S1, filed in conjunction with its January 20, 2010 financing, went effective in March 19, 2010 without review of the SEC. The Crone Law Group represented the company in both the financing and SEC registration.


The Crone Law Group Represents Qingdao Hongguan Shoes Co., Ltd. in Reverse Acquisition.
The Crone Law Group (the "Firm" or "CLG"), a boutique law firm providing strategic legal services for emerging companies, entrepreneurs and publicly traded entities, announced today that it represented Qingdao Hongguan Shoes Co., Ltd. ("Qingdao Shoes"), a Qingdao, China based designer and retailer of branded footwear, in its reverse acquisition of the Bulletin Board company Datone, Inc. (OTC: DATI) effective February 12, 2010.


The Crone Law Group Acts as Counsel in China Ritar Power Corp. $12.9 million Registered Direct Offering.
The Crone Law Group represents China Ritar Power Corp. (NASDAQ: CRTP) in $12.9 million registered direct offering. The closing occurred on October 5, 2009. Matthew Chang and Mark Crone acted as counsel on the transaction.


The Crone Law Group Acts as Counsel in China North East Petroleum Holdings $18.4 Million Registered Direct Offering.
The Crone Law Group represents China North East Petroleum Holdings Ltd. (AMEX: NEP) in $18.4 million registered direct offering. The closing occurred on September 21, 2009. Matthew Chang and Mark Crone acted as counsel on the transaction.


China North East Petroleum Holdings S3 Goes Effective.
China North East Petroleum Holdings Ltd's (AMEX: NEP) S3 went effective in September of 2009. The Crone Law Group represented the company in the SEC registration.


China Ritar Power Corp. Effectiveness Order States: S3 Goes Effective without SEC Review.
China Ritar Power Corp.'s (NASDAQ: CRTP) S3 went effective in August of 2009 without review of the SEC. The Crone Law Group represented the company in the SEC registration.


The Crone Law Group Acts as Lead Investor's Counsel in China Industrial Waste $3.0 Million PIPE Transaction.
The Crone Law Group represents lead investor in China Industrial Waste's (OTCBB: CIWT) $3.0 million PIPE transaction. Multiple closings occurred in September, 2008. Adam Guttmann and Mark Crone acted as counsel on the transaction.


The Crone Law Group Represents SinoHub in $7.0 Million PIPE Transaction.
The Crone Law Group represented SinoHub Inc. (OTCBB: SIHI) in a $7.0 million PIPE Transaction which closed September 10, 2008. Mark Crone and Adam Guttmann acted as counsel on the financing.


The Crone Law Group Acts as Lead Investor's Counsel in China Industrial Waste $3.0 Million PIPE Transaction.
The Crone Law Group represents lead investor in China Industrial Waste's (OTCBB: CIWT) $3.0 million PIPE transaction. Multiple closings occurred in September, 2008. Adam Guttmann and Mark Crone acted as counsel on the transaction.


The Crone Law Group Represents Universal Solar Technology in Best Efforts Initial Public Offering.
Mark Crone and Adam Guttmann represented Universal Solar Technology, Inc., a Zhuhai, China-based manufacturer of solar panels, in its Best Efforts IPO. The S-1 registration statement went effective on June 30, 2008.


The Crone Law Group Represents China Kangtai Cactus in second $250,000 PIPE Transaction.
The Crone Law Group represented China Kangtai Cactus Bio-Tech, Inc. (OTCBB: CKGT) in a second $250,000 PIPE Transaction which closed on July 16, 2008. Mathew Chang again acted as counsel on the transaction.


The Crone Law Group Acts as Lead Investor's Counsel in China Pharma's $10.0 Million PIPE Transaction.
The Crone Law Group represents lead investor in China Pharma Holdings, Inc. (OTCBB: CPHI) $10.0 million PIPE Transaction which closed in May, 2008. Adam Guttmann and Mark Crone acted as counsel on the transaction.


The Crone Law Group Represents China Kangtai Cactus in $500,000 PIPE Transaction.
The Crone Law Group represented China Kangtai Cactus Bio-Tech, Inc. (OTCBB: CKGT) in a $500,000 PIPE Transaction which was consummated on March 21, 2008. Mathew Chang acted as counsel on the transaction.


The Crone Law Group Represents SinoHub in Reverse Merger.
The Crone Law Group represented SinoHub Inc., a high tech logistics company based in Shenzhen, China, in a revers merger with Liberty Alliance Inc. (OTCBB: LBTI). The transaction was consummated on May 14, 2008.


The Crone Law Group Represents the Founders of Ovation on the Sale of the Company.
The Crone Law Group acted as counsel to Novato, which provides technical support outsourcing for clients globally through its subsidiary in Manila, Philippines, in the sale of all of the company to Tec Team Global, Inc. (NASDAQ: TEAM). The purchase price totaled $6,000,000, including a portion of the purchase price placed into escrow. Adam Guttmann was lead counsel on the transaction. The sale was consummated in June, 2008.


The Crone Law Group Represents Lead Investor in $2.0 Million Financing to China Based Wealth Link.
The Crone Law Group represented the lead investor in pre-reverse merger bridge financing in the amount of $2.0 million to China-based Wealth Link. The financing closed in April, 2008.


The Crone Law Group Represented China North East Petroleum Holdings Ltd. in $15.0 Million Debt Financing.
The Crone Law Group represented China North East Petroleum Holdings Ltd. (OTCBB: CNEH) in connection with a $15.0 million debt financing transaction and associated warrants, which closed February 28, 2008. Mathew Chang, with assistance from Adam Guttmann and Mark Crone, was counsel on this transaction.


The Crone Law Group Represented China Natural Gas, Inc. in $40.0 Million Debt Financing.
The Crone Law Group represented China Natural Gas, Inc. (OTCBB: CHNG) in connection with a $40.0 million debt financing transaction and associated warrants, which closed on January 29, 2008. Sandy Roynko, Mark Crone and Mathew Chang were counsel on this transaction.


Huifeng Bio-Pharmaceutical Technology, Inc. Effectiveness Order States: S1 Goes Effective without SEC Review.
Huifeng Bio-Pharmaceutical Technology, Inc.'s (OTCBB: HFGB) S1, filed in conjunction with its December 31, 2007 financing, went effective in February of 2008 without review of the SEC. The Crone Law Group represented the company in both the financing and SEC registration.


The Crone Law Group Represents American Ethanol in Consummation of Revers Merger.
The Crone Law Group represented American Ethanol, Inc., a developer of large-scale ethanol and biodiesel plants, with operations located primarily in the Midwestern United States (ethanol), and in India (biodiesel), in a reverse merger with Marwich II, Ltd. (OTCBB: MWII). Alisande Rosynko was the lead attorney for this transaction.


China Natural Gas, Inc. SB2 Goes Effective without SEC Review.
China Natural Gas, Inc.'s SB2, prepared by The Crone Law Group and filed in conjunction with its August 3, 2007 financing, went effective in December of 2007 without review of the SEC.